Back to UBS Group AG UBS Group AG

GLMDGLMD
8 quarters

Position history for UBS Group AGUBS Group AG's holdings in GALMED PHARMACEUTICALS LTD

UBS Group AG holds 3 shares of GLMD (GALMED PHARMACEUTICALS LTD), worth $2 as of 2026-Q2. The position was decreased (-99.9% shares).

Current Value

$2

Current Shares

3

Total Value Change

-$36,130

Total Shares Change

-5,264

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3
-99.9%
$20.0%$0.56
0
2026-Q1
Increased
2,546
+40.4%
$1,2480.0%$0.49
10
2025-Q4
Increased
1,814
+88.4%
$1,3600.0%$0.75
12
2025-Q3
Decreased
963
-86.0%
$1,3290.0%$1.38
0
2025-Q2
Increased
6,903
+525.3%
$12,7020.0%$1.84
19
2025-Q1
Decreased
1,104
-83.6%
$1,5890.0%$1.44
0
2024-Q4
Increased
6,721
+27.6%
$21,4400.0%$3.19
16
2024-Q3
New
5,267
-
$36,1320.0%$6.86
30

Other major holders of GLMD: TWO SIGMA INVESTMENTS, LP, Schonfeld Strategic Advisors LLC, CITADEL ADVISORS LLC, MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used